Figure 6
Figure 6. In vivo stimulation of F36V-Mpl signaling in human multilymphoid progenitors. (A) In vivo longitudinal imaging of luciferase expression in 2 NOD/SCID/β2-microglobulin−/− mice that received transplants with CD34+CD38−Lin−CD7+ cells transduced with F36V-MPL and treated with or without CID from day 1; D indicates dorsal view; V, ventral views. (B) Quantification of signal for all animals, n = 6 mice per arm, 2 independent experiments; mean and SD; P = .001 for difference between F36V-MPL with CID and all the other groups). (C) Lineage analysis of human cells in bone marrow of representative CID-treated mouse.

In vivo stimulation of F36V-Mpl signaling in human multilymphoid progenitors. (A) In vivo longitudinal imaging of luciferase expression in 2 NOD/SCID/β2-microglobulin−/− mice that received transplants with CD34+CD38LinCD7+ cells transduced with F36V-MPL and treated with or without CID from day 1; D indicates dorsal view; V, ventral views. (B) Quantification of signal for all animals, n = 6 mice per arm, 2 independent experiments; mean and SD; P = .001 for difference between F36V-MPL with CID and all the other groups). (C) Lineage analysis of human cells in bone marrow of representative CID-treated mouse.

Close Modal

or Create an Account

Close Modal
Close Modal